Andrea M Steely1, Peter W Callas1, Daniel Neal2, Salvatore T Scali2, Philip P Goodney3, Andres Schanzer4, Jack L Cronenwett3, Daniel J Bertges5. 1. Division of Vascular Surgery, University of Vermont Medical Center, Burlington, VT. 2. Division of Vascular Surgery, University of Florida College of Medicine, Gainesville, FL. 3. Section of Vascular Surgery, Dartmouth-Hitchcock Medical Center, Lebanon, NH. 4. Division of Vascular Surgery, University of Massachusetts Medical School, Worcester, MA. 5. Division of Vascular Surgery, University of Vermont Medical Center, Burlington, VT. Electronic address: daniel.bertges@uvmhealth.org.
Abstract
BACKGROUND: The aim of this study is to assess for regional variation in the incidence of postoperative myocardial infarction (POMI) following nonemergent vascular surgery across the United States to identify potential areas for quality improvement initiatives. METHODS: We evaluated POMI rates across 17 regional Vascular Quality Initiative (VQI) groups that comprised 243 centers with 1,343 surgeons who performed 75,057 vascular operations from 2010 to 2014. Four procedures were included in the analysis: carotid endarterectomy (CEA, n = 39,118), endovascular abdominal aortic aneurysm (AAA) repair (EVAR, n = 15,106), infrainguinal bypass (INFRA, n = 17,176), and open infrarenal AAA repair (OAAA, n = 3,657). POMI was categorized by the method of diagnosis as troponin-only or clinical/ECG and rates were investigated in regions with ≥100 consecutive cases. Regions with significantly different POMI rates were defined as those >1.5 interquartile lengths beyond the 75th percentile of the distribution. Risk-adjusted rates of POMI were assessed using the VQI Cardiac Risk Index all-procedures prediction model to compare the observed versus expected rates for each region. RESULTS: Overall rates of POMI varied by procedure type: CEA 0.8%, EVAR 1.1%, INFRA 2.7%, and OAAA 4.2% (P < 0.001). Significant variation in POMI rates was observed between regions, resulting in differing ranges of POMI rates for each procedure: CEA 0.5-2.0% (P = 0.001), EVAR 0.3-3.1% (P < 0.001), INFRA 1.1-4.8% (P < 0.001), and OAAA 2.2-10.0% (P < 0.001). A single region in 3 of the 4 procedure-specific datasets was identified as a statistical outlier with a significantly higher POMI rate after CEA, EVAR, and OAAA; this region was identical for the EVAR and OAAA datasets but was a different region for the CEA dataset. No significant variation in POMI was noted between regions after INFRA. Procedure-specific clinical POMI rates (mean; range) were significantly different between regions for EVAR (0.4%; 0-1.1%, P = 0.01) and INFRA (1.4%; 0.5-2.9%, P = 0.01), but not for CEA (0.4%; 0-0.8%, P = 0.53) or OAAA (1.6%; 0-3.8%, P = 0.23). Procedure-specific troponin-only POMI rates (mean; range) were significantly different between regions for all procedures: CEA (0.4%; 0.1-1.2%, P < 0.001), EVAR (0.7%; 0-2.1%, P < 0.001), INFRA (1.3%; 0.4-2.5%, P = 0.001), and OAAA (2.5%; 0-8.5%, P < 0.001). After risk adjustment, regional variation was again noted with 3 regions having higher and 4 regions having lower than expected rates of POMI. CONCLUSIONS: Significant variation in POMI rates following major vascular surgery exists across VQI regions even after risk adjustment. These findings may present an opportunity for focused regional quality improvement efforts.
BACKGROUND: The aim of this study is to assess for regional variation in the incidence of postoperative myocardial infarction (POMI) following nonemergent vascular surgery across the United States to identify potential areas for quality improvement initiatives. METHODS: We evaluated POMI rates across 17 regional Vascular Quality Initiative (VQI) groups that comprised 243 centers with 1,343 surgeons who performed 75,057 vascular operations from 2010 to 2014. Four procedures were included in the analysis: carotid endarterectomy (CEA, n = 39,118), endovascular abdominal aortic aneurysm (AAA) repair (EVAR, n = 15,106), infrainguinal bypass (INFRA, n = 17,176), and open infrarenal AAA repair (OAAA, n = 3,657). POMI was categorized by the method of diagnosis as troponin-only or clinical/ECG and rates were investigated in regions with ≥100 consecutive cases. Regions with significantly different POMI rates were defined as those >1.5 interquartile lengths beyond the 75th percentile of the distribution. Risk-adjusted rates of POMI were assessed using the VQI Cardiac Risk Index all-procedures prediction model to compare the observed versus expected rates for each region. RESULTS: Overall rates of POMI varied by procedure type: CEA 0.8%, EVAR 1.1%, INFRA 2.7%, and OAAA 4.2% (P < 0.001). Significant variation in POMI rates was observed between regions, resulting in differing ranges of POMI rates for each procedure: CEA 0.5-2.0% (P = 0.001), EVAR 0.3-3.1% (P < 0.001), INFRA 1.1-4.8% (P < 0.001), and OAAA 2.2-10.0% (P < 0.001). A single region in 3 of the 4 procedure-specific datasets was identified as a statistical outlier with a significantly higher POMI rate after CEA, EVAR, and OAAA; this region was identical for the EVAR and OAAA datasets but was a different region for the CEA dataset. No significant variation in POMI was noted between regions after INFRA. Procedure-specific clinical POMI rates (mean; range) were significantly different between regions for EVAR (0.4%; 0-1.1%, P = 0.01) and INFRA (1.4%; 0.5-2.9%, P = 0.01), but not for CEA (0.4%; 0-0.8%, P = 0.53) or OAAA (1.6%; 0-3.8%, P = 0.23). Procedure-specific troponin-only POMI rates (mean; range) were significantly different between regions for all procedures: CEA (0.4%; 0.1-1.2%, P < 0.001), EVAR (0.7%; 0-2.1%, P < 0.001), INFRA (1.3%; 0.4-2.5%, P = 0.001), and OAAA (2.5%; 0-8.5%, P < 0.001). After risk adjustment, regional variation was again noted with 3 regions having higher and 4 regions having lower than expected rates of POMI. CONCLUSIONS: Significant variation in POMI rates following major vascular surgery exists across VQI regions even after risk adjustment. These findings may present an opportunity for focused regional quality improvement efforts.
Authors: Jeffrey A Kalish; Alik Farber; Karen Homa; Magdiel Trinidad; Adam Beck; Mark G Davies; Larry W Kraiss; Jack L Cronenwett Journal: J Vasc Surg Date: 2014-06-20 Impact factor: 4.268
Authors: P J Devereaux; Matthew T V Chan; Pablo Alonso-Coello; Michael Walsh; Otavio Berwanger; Juan Carlos Villar; C Y Wang; R Ignacio Garutti; Michael J Jacka; Alben Sigamani; Sadeesh Srinathan; Bruce M Biccard; Clara K Chow; Valsa Abraham; Maria Tiboni; Shirley Pettit; Wojciech Szczeklik; Giovanna Lurati Buse; Fernando Botto; Gordon Guyatt; Diane Heels-Ansdell; Daniel I Sessler; Kristian Thorlund; Amit X Garg; Marko Mrkobrada; Sabu Thomas; Reitze N Rodseth; Rupert M Pearse; Lehana Thabane; Matthew J McQueen; Tomas VanHelder; Mohit Bhandari; Jackie Bosch; Andrea Kurz; Carisi Polanczyk; German Malaga; Peter Nagele; Yannick Le Manach; Martin Leuwer; Salim Yusuf Journal: JAMA Date: 2012-06-06 Impact factor: 56.272
Authors: P J Devereaux; Denis Xavier; Janice Pogue; Gordon Guyatt; Alben Sigamani; Ignacio Garutti; Kate Leslie; Purnima Rao-Melacini; Sue Chrolavicius; Homer Yang; Colin Macdonald; Alvaro Avezum; Luc Lanthier; Weijiang Hu; Salim Yusuf Journal: Ann Intern Med Date: 2011-04-19 Impact factor: 25.391
Authors: Daniel J Bertges; Dan Neal; Andres Schanzer; Salvatore T Scali; Philip P Goodney; Jens Eldrup-Jorgensen; Jack L Cronenwett Journal: J Vasc Surg Date: 2016-07-19 Impact factor: 4.268
Authors: Dennis T Ko; Yongfei Wang; David A Alter; Jeptha P Curtis; Saif S Rathore; Therese A Stukel; Fredrick A Masoudi; Joseph S Ross; JoAnne M Foody; Harlan M Krumholz Journal: J Am Coll Cardiol Date: 2008-02-19 Impact factor: 24.094
Authors: Dhaval Kolte; Sahil Khera; Wilbert S Aronow; Marjan Mujib; Chandrasekar Palaniswamy; Ali Ahmed; William H Frishman; Gregg C Fonarow Journal: Clin Cardiol Date: 2014-01-29 Impact factor: 2.882
Authors: Judith A R van Waes; Hendrik M Nathoe; Jurgen C de Graaff; Hans Kemperman; Gert Jan de Borst; Linda M Peelen; Wilton A van Klei Journal: Circulation Date: 2013-05-10 Impact factor: 29.690
Authors: L Pilote; R M Califf; S Sapp; D P Miller; D B Mark; W D Weaver; J M Gore; P W Armstrong; E M Ohman; E J Topol Journal: N Engl J Med Date: 1995-08-31 Impact factor: 91.245
Authors: Robert J Beaulieu; Danielle C Sutzko; Jeremy Albright; Erin Jeruzal; Nicholas H Osborne; Peter K Henke Journal: JAMA Surg Date: 2020-02-01 Impact factor: 14.766
Authors: Philip Urban; Roxana Mehran; Roisin Colleran; Dominick J Angiolillo; Robert A Byrne; Davide Capodanno; Thomas Cuisset; Donald Cutlip; Pedro Eerdmans; John Eikelboom; Andrew Farb; C Michael Gibson; John Gregson; Michael Haude; Stefan K James; Hyo-Soo Kim; Takeshi Kimura; Akihide Konishi; John Laschinger; Martin B Leon; P F Adrian Magee; Yoshiaki Mitsutake; Darren Mylotte; Stuart Pocock; Matthew J Price; Sunil V Rao; Ernest Spitzer; Norman Stockbridge; Marco Valgimigli; Olivier Varenne; Ute Windhoevel; Robert W Yeh; Mitchell W Krucoff; Marie-Claude Morice Journal: Eur Heart J Date: 2019-08-14 Impact factor: 29.983
Authors: Philip Urban; Roxana Mehran; Roisin Colleran; Dominick J Angiolillo; Robert A Byrne; Davide Capodanno; Thomas Cuisset; Donald Cutlip; Pedro Eerdmans; John Eikelboom; Andrew Farb; C Michael Gibson; John Gregson; Michael Haude; Stefan K James; Hyo-Soo Kim; Takeshi Kimura; Akihide Konishi; John Laschinger; Martin B Leon; P F Adrian Magee; Yoshiaki Mitsutake; Darren Mylotte; Stuart Pocock; Matthew J Price; Sunil V Rao; Ernest Spitzer; Norman Stockbridge; Marco Valgimigli; Olivier Varenne; Ute Windhoevel; Robert W Yeh; Mitchell W Krucoff; Marie-Claude Morice Journal: Circulation Date: 2019-05-22 Impact factor: 29.690